Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NTRA exchanges : Nasdaq save search
Liberty All-Star® Growth Fund, Inc. March 2024 Monthly Update
Published: 2024-04-12 (Crawled : 00:20) - prnewswire.com
AMZN | $182.225 0.52% 9.7M
|
Retail Trade
| Email alert
Add to watchlist
TRNS | $106.275 1.5% 3.9K
|
Electronic Technology
| Email alert
Add to watchlist
PGNY | News | $33.355 1.85% 100K
|
Commercial Services
| Email alert
Add to watchlist
VERX | $29.22 0.03% 40K
|
Technology Services
| Email alert
Add to watchlist
SPSC | $163.52 1.13% 28K
|
Technology Services
| Email alert
Add to watchlist
NTRA | $89.425 -1.0% 110K
|
Health Services
| Email alert
Add to watchlist
CWST | $92.61 0.17% 21K
|
Industrial Services
| Email alert
Add to watchlist
EME | $340.37 0.35% 87K
|
Industrial Services
| Email alert
Add to watchlist
SITE | $160.42 -0.17% 26K
|
Distribution Services
| Email alert
Add to watchlist
CR | $131.41 0.98% 24K
|
Producer Manufacturing
| Email alert
Add to watchlist
star update liberty growth
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published: 2024-04-11 (Crawled : 00:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -0.36%
H: 0.0%
C: 0.0%
kidney publication study
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 0.92%
H: 0.26%
C: -2.26%
test for heart
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 2.12%
H: 4.35%
C: 2.25%
bladder positive cancer trial
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -0.6%
H: 2.8%
C: 2.25%
cancer trials trial
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Published: 2024-03-18 (Crawled : 12:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 0.19%
H: 1.46%
C: 0.48%
cancer trial
Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 0.07%
H: 1.68%
C: 1.65%
breast meeting
Natera to Participate in March Investor Conferences
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 11.99%
H: 5.68%
C: 0.89%
Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -1.86%
H: 2.81%
C: 2.47%
conference
Liberty All-Star® Growth Fund, Inc. January 2024 Monthly Update
Published: 2024-02-13 (Crawled : 23:00) - prnewswire.com
SITE | $160.42 -0.17% 26K
|
Distribution Services
|
| O: 5.13%
H: 4.44%
C: 3.2%
DT 4 | $46.48 4.61% 1.3M
|
Technology Services
|
| O: 0.85%
H: 1.33%
C: 0.5%
CR | $131.41 0.98% 24K
|
Producer Manufacturing
|
| O: 1.1%
H: 1.6%
C: 0.56%
WDAY S | $256.5 -0.2% 330K
|
Technology Services
|
| O: 0.9%
H: 1.46%
C: 0.95%
VERX | $29.22 0.03% 40K
|
Technology Services
|
| O: 0.12%
H: 3.29%
C: 3.17%
TRNS | $106.275 1.5% 3.9K
|
Electronic Technology
|
| O: 0.84%
H: 0.97%
C: -0.25%
SPSC | $163.52 1.13% 28K
|
Technology Services
|
| O: 1.59%
H: 0.96%
C: -0.02%
RPD | $44.34 1.23% 40K
|
Technology Services
|
| O: 1.87%
H: 1.69%
C: 1.25%
PGNY | News | $33.355 1.85% 100K
|
Commercial Services
|
| O: 1.62%
H: 0.38%
C: -0.34%
PLMR | $78.44 2.0% 25K
|
Finance
|
| O: 0.03%
H: 6.33%
C: 4.63%
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 1.08%
H: 1.37%
C: 0.77%
CWST | $92.61 0.17% 21K
|
Industrial Services
|
| O: 0.99%
H: 3.81%
C: 3.77%
AMZN | $182.225 0.52% 9.7M
|
Retail Trade
|
| O: 0.34%
H: 1.18%
C: 1.05%
AGYS 4 | $81.935 -0.54% 12K
|
Technology Services
|
| O: 1.27%
H: 1.74%
C: 0.75%
star update liberty growth
New Study Validates Signatera™ in Endometrial Cancer
Published: 2024-02-05 (Crawled : 13:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -0.89%
H: 2.74%
C: 2.52%
cancer study
Carrier Screening Market Worth $5.4 Billion | MarketsandMarkets™
Published: 2024-01-31 (Crawled : 15:30) - prnewswire.com
TMO | News | $542.43 -0.88% 810K
|
Health Technology
|
| O: -0.67%
H: 0.48%
C: -4.32%
DGX | $126.75 -0.18% 120K
|
Health Services
|
| O: 0.46%
H: 0.41%
C: -0.76%
LH M | $199.19 -0.39% 72K
|
Health Services
|
| O: 0.53%
H: 0.0%
C: -2.31%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -0.2%
H: 2.4%
C: -3.7%
OPK | $1.205 -3.6% 800K
|
Health Technology
|
| O: 0.0%
H: 4.95%
C: 0.99%
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -0.76%
H: 2.2%
C: 0.67%
ILMN | $118.52 0.19% 530K
|
Health Technology
|
| O: -0.49%
H: 1.17%
C: -2.37%
CNTG | $0.4682 -2.46% 6.1K
|
Commercial Services
|
| O: -0.86%
H: 0.0%
C: -0.43%
market
New Publication Demonstrates Signatera’s Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung Cancer
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -1.07%
H: 1.73%
C: 0.46%
lung cancer publication risk
Nature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal Malignancies
Published: 2024-01-25 (Crawled : 13:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 0.59%
H: 0.64%
C: -2.09%
gastrointestinal
Invitae Completes Sale of Reproductive Health Assets to Natera
Published: 2024-01-22 (Crawled : 15:30) - biospace.com/
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -2.76%
H: 0.0%
C: 0.0%
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 2.3%
H: 1.12%
C: -2.17%
health
Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -0.31%
H: 5.34%
C: 2.24%
year
Natera Announces New Study Highlighting the Benefits of Signatera’s Unique Method of Quantifying ctDNA
Published: 2023-12-21 (Crawled : 15:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 1.62%
H: 5.36%
C: 3.57%
unique study benefits
Natera Presents New Signatera™ MRD Data Across Breast Cancer Treatment Settings at SABCS 2023
Published: 2023-12-06 (Crawled : 14:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 1.08%
H: 0.45%
C: -1.71%
breast cancer treatment sabcs
Natera Announces Real-World Data Collaboration with Merck
Published: 2023-11-14 (Crawled : 14:30) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: 2.95%
H: 4.4%
C: 4.3%
merck collaboration
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
Published: 2023-11-08 (Crawled : 21:00) - biospace.com/
NTRA | $89.425 -1.0% 110K
|
Health Services
|
| O: -0.09%
H: 0.0%
C: -5.18%
breast cancer treat trial
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0504 35.12% 300M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.